首页> 美国卫生研究院文献>BMC Cancer >The implications of clinical risk factors CAR index and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy

【2h】

The implications of clinical risk factors CAR index and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy

机译：临床风险因素汽车指数及免疫细胞对非小细胞肺癌患者免疫疗法疾病的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The online version contains supplementary material available at 10.1186/s12885-020-07727-y.

机译：在线版本包含10.1186 / s12885-020-07727-y的补充材料。

著录项

期刊名称 BMC Cancer
作者
Seo Ree Kim; Sang Hoon Chun; Joo Ri Kim; Sang-Yeob Kim; Jun Young Seo; Chan Kwon Jung; Bo-Mi Gil; Jeong-Oh Kim; Yoon Ho Ko; In Sook Woo; Byoung Yong Shim; Sook-Hee Hong; Jin Hyoung Kang;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 11
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Non-small cell lung cancer (NSCLC); Immune checkpoint blockades (ICBs); M2 macrophage; Tumor-infiltrating lymphocyte (TIL); Tumor microenvironment;

机译：非小细胞肺癌（NSCLC）;免疫检查点封闭（ICB）;M2巨噬细胞;肿瘤浸润淋巴细胞（直到）;肿瘤微环境;

相似文献

外文文献
中文文献
专利

1. The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy [J] . Seo Ree Kim, Sang Hoon Chun, Joo Ri Kim, BMC Cancer . 2021,第1期

机译：临床风险因素，汽车指数和免疫细胞对非小细胞肺癌患者免疫疾病的影响的影响
2. Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade [J] . Pranjal Vaidya, Kaustav Bera, Pradnya D Patil, Journal for ImmunoTherapy of Cancer . 2020,第2期

机译：具有免疫检查点封闭的高前来疾病风险的新型非侵入性成像方法，鉴定患有高前来疾病的高级疾病患者
3. Hyperprogressive disease in patients with non-small cell lung cancer on immunotherapy [J] . Jonathan S. Kurman, Septimiu D. Murgu Journal of Thoracic Disease . 2018,第2期

机译：非小细胞肺癌免疫疗法患者的超额前进疾病
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Symptoms Leading to Nutritional Risk in Advanced Non-Small Cell Lung Cancer Patients: The Importance of Nutritional Screening in the Advanced Lung Cancer Population [D] . Swinton, Nelda. 2009

机译：导致晚期非小细胞肺癌患者营养风险的症状：在晚期肺癌人群中进行营养筛查的重要性
6. Novel non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade [O] . Pranjal Vaidya, Kaustav Bera, Pradnya D Patil, 2020

机译：具有免疫检查点封闭的高前来疾病风险的新型非侵入性成像方法鉴定患有高前来疾病的高级疾病患者
7. The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy [O] . Seo Ree Kim, Sang hoon Chun, Jin-Hyoung Kang, 2021

机译：临床风险因素，汽车指数及免疫细胞对非小细胞肺癌患者免疫疗法疾病的影响

The implications of clinical risk factors CAR index and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy

摘要

著录项

相似文献

相关主题

期刊订阅